Dexmedetomidine Hydrochloride (BioXcel Therapeutics) | Interleukin Related interleukin-related.com

Product Name :
Dexmedetomidine Hydrochloride (BioXcel Therapeutics)

Search keywords :
Dexmedetomidine

drugId :
null

Target Vo:
Adrenergic receptors alpha-2

Target Vo Short Name :
ADRA2

Moa_Name:
Adrenergic receptors alpha-2 agonists

First Approval Country :
United States

First Approval Date Filter:
2022

Origin Company_Name :
Inveni

Active Company_Name :
Bioxcel Therapeutics Inc

Active Indication_Name:
Schizophrenia

In Active Indication_Name:
Alzheimer Disease

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BTK (YP5017) Mouse mAb supplier
Lonigutamab Autophagy
IRAK-1 Antibody: IRAK-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to IRAK-1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts